EyePoint Pharmaceuticals: Q1 Earnings Insights

EyePoint Pharmaceuticals EYPT reported its Q1 earnings results on Wednesday, May 3, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.

EyePoint Pharmaceuticals beat estimated earnings by 17.65%, reporting an EPS of $-0.56 versus an estimate of $-0.68.

Revenue was down $1.61 million from the same period last year.

Last quarter the company missed on EPS by $0.0 which was followed by a 12.8% increase in the share price the next day.

Here's a look at EyePoint Pharmaceuticals's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-0.61	-0.70	-0.52	-0.58
EPS Actual	-0.61	-0.49	-0.52	-0.56
Revenue Estimate	10.40M	10.64M	10.87M	9.89M
Revenue Actual	10.53M	10.01M	11.56M	9.29M

To track all earnings releases for EyePoint Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar